Dr. Seung Hyun Moon has two decades of experience in the biopharmaceutical industry spanning sales and marketing to medical affairs and clinical development. In his role at AlloVir, Dr. Moon leads the company’s scientific communications and KOL engagement and oversees the posoleucel multi-virus prevention study program.
Dr. Moon joined AlloVir from Alexion Pharmaceuticals, Inc., where he most recently served as executive director in the neurology franchise and business unit lead in the metabolic franchise. During his tenure, Dr. Moon was responsible for launching six different rare disease indications in various specialties in the U.S. and globally.
Dr. Moon received an MD from Yonsei University College of Medicine in South Korea and an MPA in Healthcare Management and Policy from New York University.
